Ni Yan
State Key Laboratory Of Medical Genomics
Shanghai, 200025, China
Shanghai, 200025, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Mutant p53 reactivation and DNA demethylation in the treatment of AML/MDS.
Journal: Science translational medicine
Published: August 12, 2026
RIG-I-Inducing Small Molecules Potently Inhibit HMA-Resistant AML Through Igniting the Overloaded dsRNA Arsenal.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 07, 2024
AcGlcAs: A Novel P53-Targeting Arsenical with Potent Cellular Uptake and Cancer Cell Selectivity.
Journal: Journal of medicinal chemistry
Published: December 09, 2023
Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational properties.
Journal: Science translational medicine
Published: April 05, 2023
Decitabine induces IRF7-mediated immune responses in p53-mutated triple-negative breast cancer: a clinical and translational study.
Journal: Frontiers of medicine
Published: December 20, 2022
Repurposing antiparasitic antimonials to noncovalently rescue temperature-sensitive p53 mutations.
Journal: Cell reports
Published: August 24, 2021
Decitabine activates type I interferon signaling to inhibit p53-deficient myeloid malignant cells.
Journal: Clinical and translational medicine
Published: June 22, 2021
Arsenic Trioxide Rescues Structural p53 Mutations through a Cryptic Allosteric Site.
Journal: Cancer cell
Published: December 18, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026